Beamtree Holdings Limited
BMT.AX
Get informed when a big investor buys or sells
+ FollowMarket Cap$24.13M
Close$
$0.06
38.6% downside
Current Fair Value
38.6% downsideOvervalued by 38.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $24.13 Million |
|---|---|
| Enterprise Value | $30.28 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.06 |
| Beta | 1.25 |
| Outstanding Shares | 290,696,163 |
Return
| Return on Equity | -104.62% |
|---|---|
| Return on Assets | -65.35% |
| Return on Invested Capital | -45.65% |
Valuation & Multiples
| P/E Ratio | -1.32 |
|---|---|
| PEG | -0.31 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.52 |
| Enterprise Value to EBIT | -2.7 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.29 |
| Debt to Equity | 0.37 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 27, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$14.70 M
Average shareholder expectationNext Earnings Call
Expected Date
February 17, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$14.66 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Beamtree Holdings Limited
93 employees
CEO: Gareth Pye Headquartered in Redfern, Australia, Beamtree Holdings Limited, founded in 1996, develops and markets cutting-edge clinical decision support (CDS) solutions for the healthcare sector, both within Australia and globally. The company offer...